Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

BACKGROUND: The introduction of immune checkpoint inhibitors has led to a survival benefit in patients with advanced melanoma; however data on the adoption of immunotherapy in the community are scarce. METHODS: Using the National Cancer Database, we identified 4725 patients aged ≥20 diagnosed with m...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Immunother Cancer
Главные авторы: Krimphove, Marieke J., Tully, Karl H., Friedlander, David F., Marchese, Maya, Ravi, Praful, Lipsitz, Stuart R., Kilbridge, Kerry L., Kibel, Adam S., Kluth, Luis A., Ott, Patrick A., Choueiri, Toni K., Trinh, Quoc-Dien
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836520/
https://ncbi.nlm.nih.gov/pubmed/31699149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0782-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы